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Abstract White-tailed deer (Odocoileus virginianus ) in
Michigan, USA, are wildlife reservoirs of bovine tuberculosis
(bTB) with documented spread to cattle. In vaccine efficacy
trials, Mycobacterium bovis bacillus Calmette–Guerin (BCG)
administered orally reduces colonization and bTB-associated
lesions in white-tailed deer after experimental challenge with
virulent M . bovis . The objective of this study was to develop
and evaluate the palatability of a molasses-based bait for oral
delivery of BCG to white-tailed deer. Relevant practical prop-
erties of the bait such as physical stability under various envi-
ronmental conditions were evaluated, as well as palatability.
Captive deer consumed baits within 3 h of introduction during
48 of 50 trials. Digital game cameras revealed consumption of
all placed baits by one deer over 62 % of the time. Addition of
BCG vaccine did not negatively impact palatability. Physical
stability analysis demonstrated that ice and water significantly
reduced bait stability as measured with a compression assay.
Storage of BCG-containing baits at 4 °C showed a slight
decrease in colony-forming units (CFUs) by day 31. In contrast,
storage at −20 or −80 °C over the same 31-day period showed
no significant decrease in BCG viability. The results of this
study suggest that molasses-based baits, as prepared here,
represent a plausible means of oral delivery of BCG to white-
tailed deer under most environmental conditions.
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Introduction
Mycobacterium bovis is a zoonotic pathogen found around the
world that poses a threat to livestock, wildlife, and humans. It is
the cause of bovine tuberculosis (bTB) and has been isolated
from both dairy and beef cattle herds and wild and captive
cervid populations (Nelson, 1999). Human infection may result
in disease that is clinically indistinguishable from infection with
Mycobacterium tuberculosis . Public health concerns have
prompted many countries to establish eradication/control pro-
grams for M . bovis in cattle and captive cervids. These pro-
grams have been variably successful, but it has become clear
that countries with infected wildlife face greater challenges as
wildlife acts as a reservoir of infection for cattle with resultant
wildlife-to-cattle transmission. Eradication of tuberculosis in
cattle cannot succeed unlessM . bovis is eliminated from wild-
life or wildlife-to-cattle transmission is prevented. In northeast-
ern Michigan, there is a focus of M . bovis infection in white-
tailed deer. Infected deer have been implicated as the source of
infection in over 57 cattle herds from 1988 through spring 2013
(Bill Hench, APHIS TB program staff, personal communica-
tion). In the affected area of Michigan, control measures, in-
cluding decreasing deer density through increased hunting al-
lowances, have resulted in a decrease in disease prevalence in
deer from 4.9 to 1.8 % since 1995, but prevalence continues to
remain at approximately 2 % (O’Brien et al. 2011; Carstensen
et al. 2011). Public acceptance of further decreases in deer
densities through increased hunting is waning, and additional
or alternative approaches are needed.
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Oral vaccination of wildlife has been demonstrated to be an
effective form of disease control inmultiple species (Ballesteros
et al. 2009a; Nol et al. 2008; Hermann et al. 2011, Slate et al.
2009). Delivery of the ONRAB(®) vaccine in baits has been
used widely across the USA and Canada to control rabies in
raccoons (Procyon lotor) (Roess et al. 2012, Slate et al. 2009).
Experimentally, oral vaccination of white-tailed deer with the
human vaccine, bacillus Calmette–Guerin (BCG), an attenuat-
ed strain ofM . bovis , effectively reduces the severity of disease
upon challenge with virulentM . bovis (Palmer et al. 2007; Nol
et al. 2008). Oral vaccination of deer with BCG represents a
possible control strategy in areas of highest prevalence, to
reduce deer-to-deer and deer-to-cattle transmission ofM . bovis .
However, effective vaccination requires an effective means of
delivery to the target host, such as through oral baits. A number
of factors must be considered in identification or development
of a bait delivery system. Some of these factors include knowl-
edge of host feeding behavior, seasonal or geographical effects
on bait composition, vaccine stability under various environ-
mental conditions, and attractiveness and palatability of bait to
the target host (Monaghan 1984).
Previously, free-ranging deer found liquid bait composed
of apple juice, water, glycerin, salt, and apple odor, palatable
and a plausible means of delivering pharmaceutical agents
(Hakin et al. 1996). Dry, shelled corn has been used as an
attractant in a topical acaricide delivery device designed for
white-tailed deer (Pound et al. 2000). Commercially produced
as well as homemade mineral blocks are used to attract deer
for wildlife viewing or hunting purposes. Such blocks contain
one or several ingredients believed to attract deer, such as
molasses, corn, and salt. The purpose of this study was to
develop and evaluate the palatability of a molasses-based bait
for oral delivery of BCG to white-tailed deer. It was hypoth-
esized that bait delivery would be most effective during the
winter months when food sources are depleted, encouraging
consumption of nontraditional nutrients. As such, physical
stability tests were performed at different temperature and
moisture levels relevant for deployment during the winter in
Michigan. In addition to bait physical stability, survivability of
BCG at varied temperatures and durations of storage was
determined using baits that had been inoculated with appro-
priate dosages of BCG. Bait palatability was determined from
observational studies of captive white-tailed deer using both
sham and BCG-inoculated baits.
Materials and methods
Bait composition
Molasses baits were prepared by weight using 47.47 % all
natural whole wheat flour (Gold Medal, General Mills Sales,
Inc., Minneapolis, MN, USA), 27.46 % cane molasses,
11.88 % light brown sugar (Best Choice, Wholesale
Grocers, Inc., Kansas City, KS, USA), 8.63 % water, 3.74 %
shortening (Crisco, Orrville, OH, USA), 0.49 % sodium bi-
carbonate, and 0.33 % sodium chloride. Dry ingredients were
combined prior to addition of shortening, water, and molasses.
Once thoroughly mixed, bait portions were adjusted to 8.0±
0.08 g. Baits measured approximately 1.5 cm high by 3.4 cm
in diameter (Fig. 1), small enough for deer to consume in one
piece, decreasing the risk of baits falling apart and deer not
receiving the desired dose of BCG. Baits were baked at 65 °C
for 40 min and allowed to cool to room temperature before
storage at 4 °C. Desiccant packets were added to storage bags
to reduce moisture content during refrigeration.
Physical stability test
A physical stability test evaluated factors that may affect bait
stability when placed in various environments, as described for
Escherichia coli-laden baits intended for wild boar (Ballesteros
et al. 2009a). The baits (n=72) were equally distributed to four
treatment groups based on temperature including −20, 4, 17, and
37 °C. An additional group (n=18, 17 °C) was partially sub-
merged in water while another (n=18, −1 °C) was placed in a
container of crushed ice. To quantify stability, bait compression
was analyzed using three baits from each of the temperature-
Fig. 1 Images of baits measuring
1.5 cm tall by 3.4 cm in diameter
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defined and moisture-defined treatment groups. Baits were
placed under a 300-g weight for 10 min at 9, 24, 33, 48, 57,
and 72-h intervals. Compression was quantified by measuring
bait thickness of a mean of three measurements before and after
application of the weight.
Mycobacterium bovis viability test
Mycobacterium bovis BCG Danish was used as the vaccine
strain. Bacteria were grown to mid-log phase in 175-ml flasks
(Falcon) containing Middlebrook 7H9 medium (DIFCO,
Detroit, MI, USA) supplemented with oleic–albumin–dex-
trose–catalase (OADC, DIFCO) (Buddle et al., 1995).
Bacilli were harvested by centrifugation and washed twice in
phosphate buffered saline (PBS), 0.01 M, pH 7.2, prior to
storage at −70 °C. The colony-forming units (CFUs) of BCG
were determined retrospectively by plating on 7H11 agar
plates (Becton Dickinson, Cockeysville, MD) as de-
scribed previously (Buddle et al., 1994).
BCG Danish is known to provide protection against bTB in
experimentally infected deer, is commercially available, and is
frequently used in vaccine efficacy trials with other host species
(Palmer et al. 2009; Carter et al. 2012; Tompkins et al. 2013;
Ballesteros et al. 2009b). Aseptically prepared baits were
cooled in a biological safety cabinet following baking. Baits
were inoculated with 0.025 ml of BCG suspension in four
locations for a total of 0.1 ml per bait and then frozen at −80
or −20 °C or refrigerated at 4 °C for at least 72 h. Baits were
processed for mycobacterial isolation at days 3, 17, and 31
following inoculation. Three baits per temperature treatment
were processed for mycobacterial isolation at each time period.
Each bait was cut in half, and both halves were placed in a
50-ml conical tube containing 15 ml of Middlebrook 7H9 broth
with OADC for 10 min, vortexing occasionally for an even
distribution of BCG in the diffuse bait suspension. Onemilliliter
of the BCG-bait suspension was added to 9 ml of Middlebrook
7H9 broth with OADC. Quantitative determination of BCG
concentrations was evaluated by 10-fold serial dilutions on
Middlebrook 7H11 selective agar plates with OADC, and anti-
microbial agents including polymyxin B, carbenicillin,
amphotericin B, and trimethoprim lactate after 5 weeks at
37 °C. Data on survivability were analyzed with GraphPad
Prism 4 (La Jolla, CA), using a Kruskal–Wallis nonparametric
ANOVAwith Dunn’s multiple comparison posttest.
Observations of bait consumption
The rate at which baits were consumed as well as the number
of deer eating baits was evaluated in a captive population of
white-tailed deer at the National Animal Disease Center
(Ames, IA). All animal experiments were performed with the
approval of the Institutional Animal Care and Use Committee.
Deer received pelleted maintenance feed daily in a feed trough
and alfalfa hay ad libitum. Four pens consisted of a three-sided
concrete shelter (7 m×10 m) with access to a sand/gravel-
based outdoor enclosure (12.5 m×10 m). One of the four pens
had access to an approximate 2-acre pasture. Three pens
contained three deer of mixed sexes while the fourth pen with
access to the pasture contained four bucks. The fifth pen
contained approximately 50 deer housed on a pasture. Seven
baits per pen were placed on top of the maintenance feed for a
total of 35 baits fed per day. Daily consumption was observed
for 10 days. Each pen was considered one trial per day, for a
total of 50 trials over ten consecutive business days.
Bait consumption was observed using digital game cam-
eras (RECONYX, Inc., Holmen, Wisconsin, USA), mounted
3 m above the feed troughs (Online resource 1). Close obser-
vation of unique markings and varied ear tag locations helped
distinguish between individual deer. Analysis of the near
video images placed consumption into seven categories:
“100 % consumption by one deer” referred to all of the baits
being consumed by one deer within the same time frame,
“multiple deer at feeder” when there were multiple deer in
the camera frame at once consuming baits, “same deer
returning” in which it was evident through identification that
the same deer returned to eat more baits at a later time,
“unidentifiable deer returning” indicated a deer returned to
consume more baits but was unable to be identified as a
previously observed deer, “different deer returning” indicated
that deer were able to be identified and distinguished from
each other when they returned to eat baits, “multiple deer at
feeder and unidentifiable deer returning” referred to multiple
deer in the initial camera frame eating baits but was unable to
identify the deer that returned, and “multiple deer at feeder and
different deer returning”meant there were multiple deer in the
initial camera frame eating baits and the deer that returned
were able to be distinguished from those that initially ate baits.
Palatability of baits inoculated with BCG
Preliminary bait trials using other bait matrices, such as lipid-
formulated pellets or alfalfa, demonstrated that white-tailed deer
may be able to detect BCG in baits (unpublished observations)
making them less palatable. Therefore, five baits containing
0.2 ml BCG were offered to three white-tailed deer during
January 2012 on top of the maintenance feed in the previously
described 19.5 m×10 m pens. These three deer were not
included in the bait consumption analysis described earlier.
Results
The physical stability tests showed that environmental tem-
perature alone did not significantly impact bait stability. All
baits remainedwithin 10% of their initial thickness when only
environmental temperature varied (Fig. 2). Exposure to water
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or crushed ice, in contrast, did cause a significant decrease in
bait thickness by at least 40 %.
Storage temperature (i.e., −80, −20, or 4 °C) and days at
respective various temperatures (i.e., 3, 17, and 31 days) did
not cause a significant (p >0.05) decrease in BCG viability. At
−80 °C, BCG remained viable at 7.73×106 CFU 31 days after
inoculation with 1×108 CFU of BCG compared to 5.2×
106 CFU at −20 °C and 1.32×106 CFU at 4 °C, indicating
that −80 °Cmay be an optimal storage temperature. The mean
CFU slightly decreased by day 31 in baits stored at 4 °C from
3.11×106 CFU on day 3 to 1.32×106 CFU. Although the
change by day 31 was not statistically significant from days
3 and 17 (p >0.05), it illustrates that viability is less certain if
baits are exposed to temperatures above 4 °C for over 31 days.
Near complete consumption of baits was observed repeat-
edly over 10 days when evaluating sham bait palatability.
Forty-eight of the 50 trials were completely consumed within
3 h. Review of images captured by the digital game camera
showed that >62 % of the time, all baits were consumed
immediately by a single deer. This demonstrates that placing
baits in a single location (e.g., a bait station) could cause
overconsumption of the vaccine by certain deer and inade-
quate vaccine coverage of the target population. Inoculating
baits with BCG did not have a negative impact on palatability
as all the BCG-containing baits were readily consumed.
Discussion
Efficient uptake of baits in this study demonstrates that a
molasses-based bait formulation is palatable to white-tailed deer.
However, the current study used captive deer, habituated to
regular feeding. Field studies will be necessary to determine
the attractiveness of such bait to free-ranging deer. As apple
flavor, apple odor, and corn have also been used as effective
attractants for free-ranging white-tailed deer, it may be advanta-
geous to use a combination of attractants for optimum attraction.
Results of the physical stability test determined the bait
matrix to be stable in dry conditions but unstable when in
contact with ice and water. This suggests acceptable bait stabil-
ity during winter with constant temperatures below freezing;
however, if ambient temperatures result in melting snow and
ice, bait stability will be compromised. It may prove advanta-
geous to use a device such as the “four-poster” feeder, or other
mechanism to shield baits from ice and water (Slate et al. 2009).
The current study also demonstrates that this molasses-based
bait may be a feasible means of oral delivery of BCG to white-
tailed deer. In general, virulent M . bovis can survive for days,
weeks, or even months on feedstuffs in cooler, shaded areas
(Fine et al. 2011). However, current BCG viability results
suggest decreasing viability if baits are exposed to temperatures
above 4 °C for over 31 days. A certain degree of survivability is
required of any live vaccine delivered via oral bait. The vaccine
must remain viable for a reasonable amount of time, such as the
interval from deployment to consumption. However, greatly
prolonged survivability may contaminate the environment and
increase the likelihood of nontarget species (including cattle)
exposure to vaccine. While deployment of a BCG-containing
bait in winter decreases contact with nontarget species that are
not active during winter, some nontarget exposure is likely to
occur. Vaccine safety in nontarget species is a legitimate concern
though the risk transmission of BCG to cattle was shown to be
low (Nol et al. 2013). Importantly,M . bovis BCG is one of the
oldest vaccines still in use and has been extensively used in
animal models of human tuberculosis (e.g., mice, guinea pigs,
and rabbits) with no deleterious effects (Clark et al. 2010,
Baldwin et al. 1998).
Prolonged survivability in the environment as well as
prolonged survivability within the deer represent public health
concerns, as deer (venison) is often consumed by hunters.
Examination of persistence in deer after oral or parenteral
BCG vaccination demonstrated persistence in lymphoid
tissues (i.e., lymph nodes) for extended periods, up to
12 months. However, BCG was never isolated from tissues
commonly consumed by humans (Palmer et al. 2012,
Wilkins et al. 2003). BCG is considered avirulent in im-
munocompetent hosts; however, human exposure to BCG
may induce false positive tuberculin skin test results. False
positive results are undesirable as tuberculin skin testing is
the primary means by which public health officials monitor
for human tuberculosis.
This study also revealed the potential for overconsumption
of baits by certain deer, leading to variability in dose and
inadequate vaccine coverage within the target population.
Deer consuming numerous baits not only decreases the re-
maining number of baits and negatively impacts vaccine
coverage but also results in ingestion of a greater than desired
dose of BCG by eager deer. According to Nol et al. (2008), an
oral dose of 109 CFUs provides protection to experimentally
infected deer. It is not clear what effect high BCG dosages
have on vaccine efficacy. The minimal oral dose of BCG
required to provide protection is also unclear
Fig. 2 Physical stability of baits when exposed to various temperatures
(−20, 4, 17, and 37 °C) and moisture conditions (i.e., water and ice).
Decreased stability is indicated by greater reduction in thickness in
response to application of 300-g weight for 10 min. Data are presented
as mean +/− SEM percent change in height
268 Eur J Wildl Res (2014) 60:265–270
Ultimately, such oral BCG vaccination of deer may provide a
useful tool in the tuberculosis eradication effort of the Michigan
Department of Natural Resources (MDNR). However, future
studies are needed to determine how soon after vaccination
BCG will provide protective immunity, as well as the duration
of immunity. Thom et al. (2012) determined, in cattle, that BCG
provided protection againstM . bovis at 1-year post vaccination
but not 2 years, indicating that repeated vaccination might be
required. When the timeline of protective immunity is known,
the most effective means of vaccine deployment can be deter-
mined. Piles of supplemental feed, provided by humans, are an
important factor in deer-to-deer transmission of M . bovis
(Palmer et al. 2004). Disease is transferred via exchange of
infectious excretions deposited on shared feed. Therefore, it will
be important to design a bait delivery method that does not
unnaturally congregate deer, unintentionally creating an envi-
ronment for enhanced disease transmission.
The baits developed in this study represent a plausible option
for delivery of BCG to white-tailed deer. Distribution of baits
during winter months will enhance BCG survival and limit
nontarget species exposure. Nevertheless, field evaluation of
bait consumption by nontarget species should be conducted to
determine any deleterious effects should unintended ingestion
occurs. Additionally, bait palatability studies and survivability
of BCG within baits in the field during the targeted delivery
season are needed to fully evaluate the potential for use of these
vaccine delivery baits to deliver BCG to white-tailed deer in the
TB core area of Michigan.
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